Evaluating cardiac resynchronization therapy effects in adults with congenital heart disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the real-world effects of cardiac resynchronization therapy (CRT) on adult patients with congenital heart disease (ACHD). It aims to assess whether CRT improves clinical outcomes such as QRS duration, ventricular function, and functional class in this unique population. The study involves a retrospective cohort of ACHD patients who received CRT from January 2014, analyzing data from electronic health records to identify factors associated with positive therapy responses. The findings will help clarify the efficacy and safety of CRT in ACHD, which is often overlooked in existing guidelines.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* ACHD patients who underwent CRT implantation

Exclusion Criteria:

* Less than 18 years old on the moment of CRT implantation
* Patient objection to the use of retrospective data

Where it's running

• Leiden University Medical Center (LUMC)
  Leiden, South Holland, Netherlands Recruiting

Study contacts

• Study coordinator: Anastasia D. Egorova, MD, PhD
• Email: a.egorova@lumc.nl
• Phone: +31 71 5262020

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Heart Institute Biobank and Registry for Adults with Congenital Heart Disease and Related Conditions

  This project will collect blood, tissue samples, and detailed health information from adults (≥16) with congenital heart disease and related heart or vascular conditions to create a resource researchers can use.

  Recruiting Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT07477197

• Trauma, PTSD, and resilience in adults living with congenital heart disease

  This project will test whether lifetime experiences related to congenital heart disease are linked to PTSD and whether resilience helps protect adults with CHD.

  Recruiting Dartmouth-Hitchcock Medical Center · Washington D.C., District of Columbia and 2 other locations · NCT06952933

• Evaluating the effectiveness of SGLT2 inhibitors in adults with congenital heart disease

  This study is trying to see if a new type of diabetes medication can help adults with congenital heart disease feel better and manage their heart failure symptoms.

  Recruiting at 11 sites Leiden University Medical Center · Baltimore, Maryland and 10 other locations · NCT06932081

• Identifying noninvasive markers of heart transplant rejection in patients with congenital heart disease

  This study is testing a new blood test to see if it can help detect heart transplant rejection in patients with congenital heart disease without needing a more invasive procedure.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna · NCT06784440

• Observational study of adults with congenital heart disease

  This study looks at how adults with congenital heart disease are managed at a specialized center to see how their health is doing and what kind of care they need.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna · NCT06769529

• Evaluating long-term outcomes in adults with congenital heart disease

  This study looks at adults with congenital heart disease to see what factors might lead to serious health issues over time, while they continue their regular check-ups.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome, RM · NCT06723704

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.